Irene Kuhn

Title: The Innovative Contributions of Irene Kuhn

Introduction

Irene Kuhn is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines for poultry. With a total of 2 patents, her work focuses on enhancing the immune response in chickens against specific infections.

Latest Patents

Irene's latest patents include groundbreaking research on DNA encoding an antigenic protein derived from Eimeria tenella. This research provides nucleic acid molecules that encode antigenic proteins capable of inducing an immune response in chickens, thereby conferring protection against Eimeria tenella. Additionally, her patents detail methods for producing these proteins or antigenic polypeptides, which are crucial for vaccine development. One of her patents describes a genomic DNA molecule that encodes a 25,000 dalton antigenic protein, composed of two polypeptides linked by a disulfide bond. These polypeptides are essential for creating effective vaccines to immunize chickens against Eimeria tenella infections.

Career Highlights

Irene Kuhn is currently employed at Solvay & Cie, where she continues to innovate in the field of biotechnology. Her work has been instrumental in advancing vaccine technology, particularly for the poultry industry.

Collaborations

Irene collaborates with esteemed colleagues such as William H. Andrews and Virginia M. Brothers, contributing to a dynamic research environment that fosters innovation and development.

Conclusion

Irene Kuhn's contributions to biotechnology, particularly in vaccine development for poultry, highlight her role as a leading inventor in her field. Her innovative patents and collaborative efforts continue to make a significant impact on animal health and agricultural practices.